The largest database of trusted experimental protocols

Rabbit anti human vegfa antibody

Manufactured by Proteintech
Sourced in China

This Rabbit anti-Human VEGFA antibody is a primary antibody that specifically binds to the human Vascular Endothelial Growth Factor A (VEGFA) protein. VEGFA is a key regulator of angiogenesis, the process of new blood vessel formation.

Automatically generated - may contain errors

2 protocols using rabbit anti human vegfa antibody

1

Western Blot Analysis of Vascular Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The isolated cells were lysed in lysis buffer. The protein concentration was then determined. Equal amounts of protein were analysed by SDS‐PAGE, followed by electrophoretic transfer to PVDF membranes (Millipore Corp., Billerica, MA, USA). The membrane was blocked for 1 hour with 5 mL blocking buffer (5% skim milk in TBST) and incubated overnight at 4°C with 5% skim milk diluted primary antibody: Rabbit anti‐Human VE‐cadherin antibody (1:500 dilutions, ProteinTech); Rabbit anti‐Human VEGFA antibody (1:500 dilutions, ProteinTech); and Rabbit anti‐Human GAPDH antibody (1:500 dilutions, ProteinTech). The next day, the membranes were washed three times with TBST and incubated with 2% skim milk diluted secondary antibody for 2 hour. After washing, the immunoreactive protein bands were visualized using the BIO‐RAD gel imaging system. GAPDH was used as an internal control.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of CRC Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 125 pairs of CRC samples and adjacent normal tissues were obtained from CRC patients at the First Affiliated Hospital of Soochow University (Suzhou, China). All experiments involving patient specimens were approved by the Institutional Review Board of Soochow University. Informed consent was obtained from each patient. Detailed clinicopathological information is provided in Supplementary Table S1. An IHC assay was conducted as previously described17 (link). Briefly, CRC samples or xenograft tumor samples were deparaffinized and rehydrated. After antigen retrieval with 10 mM sodium citrate buffer (pH 6.0), the sections were incubated with goat anti-human 4IgB7-H3 antibody (R&D Systems, MN, USA, #AF1027, 1:100), mouse anti-human CD31 antibody (Abcam, Cambridge, MA, USA, #ab32457, 1:1500), or rabbit anti-human VEGFA antibody (Proteintech, Wuhan, China, #19003–1-AP, 1:500). All sections were then reviewed blindly by two experienced pathologists (Dr. Cao and Dr. Zhan). The scoring criteria for IHC staining were based on the intensity of immunostaining and the percentage of immunoreactive cells as described previously17 (link). We calculated the score of the MVD on the basis of previously described criteria22 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!